Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study

PURPOSE: It has been proved that the gut microbiome is altered in patients with chronic kidney disease. This contributes to chronic inflammation and increases cardiovascular risk and mortality, especially in those undergoing hemodialysis. Phosphate binders may potentially induce changes in their mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Merino-Ribas, Ana, Araujo, Ricardo, Bancu, Ioana, Graterol, Fredzzia, Vergara, Andrea, Noguera-Julian, Marc, Paredes, Roger, Bonal, Jordi, Sampaio-Maia, Benedita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262763/
https://www.ncbi.nlm.nih.gov/pubmed/34923600
http://dx.doi.org/10.1007/s11255-021-03091-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262763/
https://www.ncbi.nlm.nih.gov/pubmed/34923600
http://dx.doi.org/10.1007/s11255-021-03091-3

Ejemplares similares